DGX
Price
$182.10
Change
+$2.90 (+1.62%)
Updated
Aug 29, 03:55 PM (EDT)
Capitalization
20.04B
60 days until earnings call
STSS
Price
$13.51
Change
-$2.52 (-15.72%)
Updated
Aug 29, 04:20 PM (EDT)
Capitalization
16.4M
Interact to see
Advertisement

DGX vs STSS

Header iconDGX vs STSS Comparison
Open Charts DGX vs STSSBanner chart's image
Quest Diagnostics
Price$182.10
Change+$2.90 (+1.62%)
Volume$200
Capitalization20.04B
Sharps Technology
Price$13.51
Change-$2.52 (-15.72%)
Volume$750
Capitalization16.4M
DGX vs STSS Comparison Chart in %
Loading...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DGX vs. STSS commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Buy and STSS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (DGX: $179.20 vs. STSS: $16.03)
Brand notoriety: DGX and STSS are both not notable
DGX represents the Medical Specialties, while STSS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DGX: 55% vs. STSS: 395%
Market capitalization -- DGX: $20.04B vs. STSS: $16.4M
DGX [@Medical Specialties] is valued at $20.04B. STSS’s [@Pharmaceuticals: Other] market capitalization is $16.4M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.55B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGX’s FA Score shows that 2 FA rating(s) are green whileSTSS’s FA Score has 0 green FA rating(s).

  • DGX’s FA Score: 2 green, 3 red.
  • STSS’s FA Score: 0 green, 5 red.
According to our system of comparison, DGX is a better buy in the long-term than STSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGX’s TA Score shows that 5 TA indicator(s) are bullish while STSS’s TA Score has 6 bullish TA indicator(s).

  • DGX’s TA Score: 5 bullish, 4 bearish.
  • STSS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DGX is a better buy in the short-term than STSS.

Price Growth

DGX (@Medical Specialties) experienced а -2.46% price change this week, while STSS (@Pharmaceuticals: Other) price change was +153.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.81%. For the same industry, the average monthly price growth was +7.40%, and the average quarterly price growth was +7.26%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.55%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

DGX is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Medical Specialties (-0.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DGX($20B) has a higher market cap than STSS($16.4M). DGX YTD gains are higher at: 20.496 vs. STSS (-97.406). DGX has higher annual earnings (EBITDA): 2.07B vs. STSS (-10.23M). DGX has more cash in the bank: 319M vs. STSS (8.32M). STSS has less debt than DGX: STSS (2.33M) vs DGX (6.38B). DGX has higher revenues than STSS: DGX (10.5B) vs STSS (223K).
DGXSTSSDGX / STSS
Capitalization20B16.4M121,951%
EBITDA2.07B-10.23M-20,219%
Gain YTD20.496-97.406-21%
P/E Ratio21.46N/A-
Revenue10.5B223K4,708,520%
Total Cash319M8.32M3,833%
Total Debt6.38B2.33M273,522%
FUNDAMENTALS RATINGS
DGX: Fundamental Ratings
DGX
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
35
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
29
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DGXSTSS
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
64%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROBN59.600.75
+1.27%
T-Rex 2X Long HOOD Daily Target ETF
SFEB22.470.01
+0.07%
FT Vest U.S. Small Cap Mod Buf ETF-Feb
NPCT10.87N/A
+0.05%
Nuveen Core Plus Impact Fund
HYLS42.000.01
+0.04%
First Trust Tactical High Yield ETF
FDHT21.47-0.17
-0.77%
Fidelity Digital Health ETF

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been loosely correlated with LH. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
-0.31%
LH - DGX
59%
Loosely correlated
-1.18%
SYK - DGX
43%
Loosely correlated
-0.89%
IQV - DGX
42%
Loosely correlated
-0.04%
MDT - DGX
40%
Loosely correlated
-0.10%
ABT - DGX
40%
Loosely correlated
-0.07%
More

STSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STSS has been loosely correlated with SINT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if STSS jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STSS
1D Price
Change %
STSS100%
+8.02%
SINT - STSS
60%
Loosely correlated
+12.17%
HSDT - STSS
36%
Loosely correlated
+0.40%
CATX - STSS
23%
Poorly correlated
-6.37%
DGX - STSS
23%
Poorly correlated
-0.31%
MYNZ - STSS
22%
Poorly correlated
+1.85%
More